Share on StockTwits

Analysts at Deutsche Bank increased their price objective on shares of CSL Limited (ASX:CSL) from $71.00 to $78.00 in a research report issued to clients and investors on Friday, reports. The firm currently has a “buy” rating on the stock.

CSL Limited (ASX:CSL) traded down 0.73% during mid-day trading on Friday, hitting A$70.260. 1,838,530 shares of the company’s stock traded hands. CSL Limited has a one year low of A$53.920 and a one year high of A$71.200. The stock has a 50-day moving average of A$68.39 and a 200-day moving average of A$67.00. The company has a market cap of A$34.241 billion and a price-to-earnings ratio of 29.12.

Several other analysts have also recently commented on the stock. Analysts at Credit Suisse reiterated an “outperform” rating on shares of CSL Limited in a research note to investors on Friday, January 24th. They now have a $74.55 price target on the stock. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of A$73.76 ($64.14).

CSL Limited is an Australia-based company. The Company is engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.